Beranda › Kanker Rahim › New York
Uji klinis Kanker Rahim di New York
8 studi untuk Kanker Rahim mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Maimonides Medical Center, Brooklyn
- Columbia University Medical Center - Herbert Irving Pavilion, New York
- IP Address: Columbia University Medical Center/New York Presbyterian Hospital Research Pharmacy, New York
Menerima pesertaFase 4
Usia 18 ke atas · Wanita · Diperbarui 25 Sep 2026 · NCT06952660DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, New York
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 3 Sep 2026 · NCT06989112PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
- Northwell Health Cancer Institute at Huntington, Greenlawn
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT04329494Investigations of Reproductive Cancers in Women
- Columbia University, New York
Menerima pesertaStudi observasional
Usia 45 hingga 100 · Wanita · Diperbarui 17 Agu 2026 · NCT06527157Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
- Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology, New York
Menerima pesertaFase 1/2
Usia 18 ke atas · Wanita · Diperbarui 13 Agu 2026 · NCT06040970Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Brooklyn
- Research Site, Stony Brook
- Research Site, The Bronx
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 29 Jul 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 2
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
Menerima pesertaStudi observasional
30 Days · Semua jenis kelamin · Diperbarui 3 Mar 2025 · NCT06203106Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.